Coronaviruses Research in BRICS Countries
SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral–host interactions. Now, with the global rollout of various COVID-19 vaccines—ba...
Saved in:
| Format: | Online |
|---|---|
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | ONIX_20220621_9783036540283_19 |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1869531089291182080 |
|---|---|
| collection | Directory of Open Access Books |
| description | SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral–host interactions. Now, with the global rollout of various COVID-19 vaccines—based on the neutralization of the spike protein using different technologies—viral immunology and cell-based immunity are being investigated. Researchers are also studying how various SARS-CoV-2 genetic mutations will impact the efficacy of these COVID-19 vaccines. At the same time, various antiviral drugs have been identified or repurposed that have potential as anti-SARS-CoV-2 treatments. BRICS (Brazil, Russia, India, China, and South Africa) is the acronym used to associate five major emerging national economies. The BRICS countries are known for their significant influence on regional affairs, including being leaders in scientific and clinical research and innovation. This Special Issue includes researchers from BRICS countries, in particular South Africa, involved in the study of SARS-CoV-2 and COVID-19. Original articles, as well as new perspectives or reviews on the matter, were welcomed. Research in the fields of vaccine studies, pathogenesis, genetic mutations, viral immunology, and antiviral drugs were especially encouraged. |
| format | Online |
| id | doab-20.500.12854ir-84441 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-844412024-03-31T13:10:32Z Coronaviruses Research in BRICS Countries Fielding, Burtram C. Schäfer, Georgia SARS-CoV-2 E484K variant of Interest genomic epidemiology Brazil immunoassay SARS-CoV-2 nucleocapsid protein epitope coverage quantitative antibody binding protein microarray SARS-CoV-2 antibodies humoral response COVID-19 nanotechnology detection treatment breakthrough VRDL Delta and Delta plus variant India vaccine dental aerosol-generating procedures extra-oral suction high-volume evacuation low-volume saliva ejector splatter aerosol convalescent plasma COVID-19 and nanotechnology nanomedicine in South Africa bioinformatics and vaccine development vaccine development in South Africa models different settings intervention strategies NSW coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome coronavirus (SARS-CoV-2) neutralizing antibody (NAb) diabetes corticosteroids reverse zoonosis wildlife COVID-19 testing hospital mortality intubation thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral–host interactions. Now, with the global rollout of various COVID-19 vaccines—based on the neutralization of the spike protein using different technologies—viral immunology and cell-based immunity are being investigated. Researchers are also studying how various SARS-CoV-2 genetic mutations will impact the efficacy of these COVID-19 vaccines. At the same time, various antiviral drugs have been identified or repurposed that have potential as anti-SARS-CoV-2 treatments. BRICS (Brazil, Russia, India, China, and South Africa) is the acronym used to associate five major emerging national economies. The BRICS countries are known for their significant influence on regional affairs, including being leaders in scientific and clinical research and innovation. This Special Issue includes researchers from BRICS countries, in particular South Africa, involved in the study of SARS-CoV-2 and COVID-19. Original articles, as well as new perspectives or reviews on the matter, were welcomed. Research in the fields of vaccine studies, pathogenesis, genetic mutations, viral immunology, and antiviral drugs were especially encouraged. 2022-06-21T08:36:02Z 2022-06-21T08:36:02Z 2022 book ONIX_20220621_9783036540283_19 9783036540283 9783036540276 https://directory.doabooks.org/handle/20.500.12854/84441 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/5424 https://mdpi.com/books/pdfview/book/5424 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-4027-6 10.3390/books978-3-0365-4027-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036540283 9783036540276 168 Basel open access |
| spellingShingle | SARS-CoV-2 E484K variant of Interest genomic epidemiology Brazil immunoassay SARS-CoV-2 nucleocapsid protein epitope coverage quantitative antibody binding protein microarray SARS-CoV-2 antibodies humoral response COVID-19 nanotechnology detection treatment breakthrough VRDL Delta and Delta plus variant India vaccine dental aerosol-generating procedures extra-oral suction high-volume evacuation low-volume saliva ejector splatter aerosol convalescent plasma COVID-19 and nanotechnology nanomedicine in South Africa bioinformatics and vaccine development vaccine development in South Africa models different settings intervention strategies NSW coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome coronavirus (SARS-CoV-2) neutralizing antibody (NAb) diabetes corticosteroids reverse zoonosis wildlife COVID-19 testing hospital mortality intubation thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics Coronaviruses Research in BRICS Countries |
| title | Coronaviruses Research in BRICS Countries |
| title_full | Coronaviruses Research in BRICS Countries |
| title_fullStr | Coronaviruses Research in BRICS Countries |
| title_full_unstemmed | Coronaviruses Research in BRICS Countries |
| title_short | Coronaviruses Research in BRICS Countries |
| title_sort | coronaviruses research in brics countries |
| topic | SARS-CoV-2 E484K variant of Interest genomic epidemiology Brazil immunoassay SARS-CoV-2 nucleocapsid protein epitope coverage quantitative antibody binding protein microarray SARS-CoV-2 antibodies humoral response COVID-19 nanotechnology detection treatment breakthrough VRDL Delta and Delta plus variant India vaccine dental aerosol-generating procedures extra-oral suction high-volume evacuation low-volume saliva ejector splatter aerosol convalescent plasma COVID-19 and nanotechnology nanomedicine in South Africa bioinformatics and vaccine development vaccine development in South Africa models different settings intervention strategies NSW coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome coronavirus (SARS-CoV-2) neutralizing antibody (NAb) diabetes corticosteroids reverse zoonosis wildlife COVID-19 testing hospital mortality intubation thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics |
| topic_facet | SARS-CoV-2 E484K variant of Interest genomic epidemiology Brazil immunoassay SARS-CoV-2 nucleocapsid protein epitope coverage quantitative antibody binding protein microarray SARS-CoV-2 antibodies humoral response COVID-19 nanotechnology detection treatment breakthrough VRDL Delta and Delta plus variant India vaccine dental aerosol-generating procedures extra-oral suction high-volume evacuation low-volume saliva ejector splatter aerosol convalescent plasma COVID-19 and nanotechnology nanomedicine in South Africa bioinformatics and vaccine development vaccine development in South Africa models different settings intervention strategies NSW coronavirus disease 2019 (COVID-19) severe acute respiratory syndrome coronavirus (SARS-CoV-2) neutralizing antibody (NAb) diabetes corticosteroids reverse zoonosis wildlife COVID-19 testing hospital mortality intubation thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics |
| url | ONIX_20220621_9783036540283_19 |